Get full access to database
Get access to investment teams contacts
Unlimited AI searches
Export funds info in CSV format
Healthcare startups often need more than funding. They need investors who understand clinical timelines, regulatory risk, product validation, reimbursement, partnerships, and the long path from early innovation to market adoption.
That is where healthcare venture capital firms play an important role. These firms back companies across biotech, digital health, medical devices, diagnostics, life sciences, healthcare services, and AI-enabled care delivery, helping founders move from research, testing, or early traction toward commercialization and scale.
OrbiMed is one of the most recognized healthcare investment firms in the world. The firm invests globally across the healthcare industry, including early stage private companies, public companies, and larger healthcare businesses. OrbiMed’s platform covers venture capital, private equity, public equity, and credit strategies, which gives it a broad view of the healthcare market in 2025 and beyond.
The firm is especially relevant for biotech, medical devices, life sciences, health tech, and healthcare services companies looking for an experienced capital partner with deep sector knowledge. OrbiMed has backed more than 110 life sciences startups and continues to support portfolio companies across global healthcare markets, including developing-country healthcare systems.
Andreessen Horowitz, often known as a16z, has a dedicated Bio + Health practice focused on founders working across medicine, biology, care delivery, and healthcare infrastructure. The firm supports companies building in areas such as life sciences, digital health, AI in healthcare, health tech, and modern care models.
a16z Bio + Health is a strong fit for any healthcare entrepreneur building at the intersection of technology, clinical science, and operational healthcare problems. Its focus includes medical breakthroughs, disease treatment, healthcare delivery, and infrastructure that can support the next generation of healthcare companies and their growing portfolio companies.
General Catalyst is a global investment firm with a major healthcare focus through its Health Assurance strategy. The firm backs healthcare companies working to make care more proactive, accessible, and technology-enabled. Its portfolio and platform include healthcare transformation efforts, applied AI, health tech, and companies improving healthcare systems.
General Catalyst has become especially visible in health tech because it looks beyond traditional startup funding and works as a long-term partner to healthcare founders. It has supported companies in care delivery, healthcare operations, infrastructure, and AI-driven healthcare workflows, making it relevant for founders building healthcare platforms in 2025.
New Enterprise Associates, or NEA, is one of the largest venture capital firms and invests across technology and healthcare. The firm supports companies from seed stage through IPO, which makes it relevant for healthcare founders at different stages of growth, including early stage companies.
NEA’s healthcare work spans biotech, medical technology, digital health, healthcare services, life sciences, and health tech. Its broad platform allows healthcare companies to access sector expertise, growth-stage support, and a strong network that can help each entrepreneur move from product development to commercialization.
Foresite Capital is a multi-stage healthcare and life sciences investment firm. The firm focuses on companies using biology, big data, and data science to transform healthcare. Its investment approach is especially relevant for companies working in genomics, diagnostics, drug discovery, therapeutics, and health technology.
Foresite is a strong example of how healthcare venture capital has moved toward data-driven company building. The firm invests across different stages of the company life cycle and looks for businesses addressing large unmet needs in healthcare and life sciences.
5AM Ventures is a life sciences venture capital firm focused on funding and building next-generation life sciences companies. The firm works with companies developing advanced therapeutics, biotechnology platforms, and other healthcare innovations.
For healthcare founders in biotech or life sciences, 5AM Ventures is relevant because it takes a company-building approach. The firm supports early scientific ideas and helps shape them into venture-backed companies with clinical, regulatory, and commercial potential.
SV Health Investors is a specialist healthcare investment platform that invests across biotechnology, healthcare growth equity, medtech, dementia, and healthcare services. The firm describes itself as a global private equity and venture capital investment platform focused on healthcare.
The firm is useful for founders looking for investors with deep healthcare experience rather than generalist capital. SV Health Investors works across stages and sectors, which makes it relevant for companies building medical devices, therapeutics, healthcare technology, and specialized healthcare services.
Optum Ventures is the venture capital arm connected to Optum, a major healthcare services and technology organization under UnitedHealth Group. Its healthcare background gives it a strong understanding of payer, provider, pharmacy, data, and care delivery challenges. Optum itself focuses on making healthcare work better through improved experiences, better outcomes, and lower costs.
Optum Ventures is especially relevant for startups building in digital health, care delivery, healthcare data, payer infrastructure, population health, and value-based care. For founders selling into healthcare systems or payers, strategic healthcare investors like Optum Ventures can offer both capital and market perspective.
Khosla Ventures is a broad venture capital firm, but it has been active in healthcare, AI, diagnostics, biotechnology, and health technology. It is often relevant for healthcare startups working at the edge of science, software, and automation.
For healthcare founders, Khosla Ventures may be a fit when the company has a bold technical vision rather than a conventional healthcare services model. Startups working on AI-enabled diagnostics, computational biology, healthcare automation, or next-generation care delivery may find the firm’s technology-first investment style relevant.
Deerfield Management is a healthcare-focused investment firm that works across therapeutics, healthcare services, medical products, and healthcare technology. It is often associated with later-stage healthcare investing, structured financing, and company formation around scientific or clinical opportunities.
For healthcare companies, Deerfield can be relevant when the business needs more than early seed capital. Companies with clinical pipelines, commercial healthcare products, or complex growth plans may benefit from a healthcare-focused investor with deep market and regulatory understanding.
Healthcare venture capital firms play a major role in helping medical, biotech, life sciences, and digital health startups grow. Firms like OrbiMed, Andreessen Horowitz Bio + Health, General Catalyst, NEA, Foresite Capital, and Deerfield Management each bring different strengths to the healthcare market.
For founders, the right investor depends on the company’s stage, sector, product type, and growth needs. A biotech startup may need a very different investor than a healthcare SaaS company, medical device startup, or care delivery platform.
Private Equity List makes this process easier by helping founders, business owners, and deal teams identify relevant investors based on industry, location, and investment focus.
Find healthcare venture capital firms faster with AI Search at Private Equity List, using smart filters for sector, deal stage, investment focus, location, and company fit.